Robin Luffy1, Susan K Grove. 1. Graduate Nursing Program, University of Texas at Arlington, Arlington, TX, USA.
Abstract
PURPOSE: To compare the validity, reliability, and preference of pain intensity measurement tools--the African-American Oucher Scale, the Wong-Baker FACES Scale, and the Visual Analog Scale (VAS)--in 100 African-American children between 3 and 18 years of age. METHODS: During a visit to the sickle cell anemia clinic, the children were asked to describe two painful procedures/treatments they had experienced and to choose which one hurt the most. They rated the pain intensity of each procedure/treatment on the three scales that were presented in a preselected order. After using all the scales, the children then chose their favorite scale. The same procedure was repeated at the end of the visit, with a minimum of 15 minutes between the test and retest. RESULTS: Concurrent validity was determined by comparing the rank order of the two identified painful items with the pain scores on the three scales. Chi square analysis indicated a statistically significant difference among the scales for preference (chi2 = 24.08, df = 2, p < 0.0001) and reliability (chi2 = 6.12, df = 2, p < 0.05), but not validity (chi2 = 0.81, df = 2, NS) for the entire sample. Most children preferred using the FACES Scale (56%) versus the Oucher (26%) and VAS (18%). When the data were analyzed for three cognitive stages (ages 3-7, 8-12, and 13-18 years), the following were found: For the school-age period, chi square for reliability did not reach significance (chi2 = 4.35, df = 2, NS); for the preschool-age period, chi square for validity did reach significance (chi2 = 6.49, df = 2, p < 0.05) and was strongest for the FACES scale, followed by the Oucher. CONCLUSIONS: The study findings indicated that the FACES and African-American Oucher Scales are valid and reliable tools for measuring pain in children. Among the entire sample and each age group, the FACES scale was the most preferred scale.
PURPOSE: To compare the validity, reliability, and preference of pain intensity measurement tools--the African-American Oucher Scale, the Wong-Baker FACES Scale, and the Visual Analog Scale (VAS)--in 100 African-American children between 3 and 18 years of age. METHODS: During a visit to the sickle cell anemia clinic, the children were asked to describe two painful procedures/treatments they had experienced and to choose which one hurt the most. They rated the pain intensity of each procedure/treatment on the three scales that were presented in a preselected order. After using all the scales, the children then chose their favorite scale. The same procedure was repeated at the end of the visit, with a minimum of 15 minutes between the test and retest. RESULTS: Concurrent validity was determined by comparing the rank order of the two identified painful items with the pain scores on the three scales. Chi square analysis indicated a statistically significant difference among the scales for preference (chi2 = 24.08, df = 2, p < 0.0001) and reliability (chi2 = 6.12, df = 2, p < 0.05), but not validity (chi2 = 0.81, df = 2, NS) for the entire sample. Most children preferred using the FACES Scale (56%) versus the Oucher (26%) and VAS (18%). When the data were analyzed for three cognitive stages (ages 3-7, 8-12, and 13-18 years), the following were found: For the school-age period, chi square for reliability did not reach significance (chi2 = 4.35, df = 2, NS); for the preschool-age period, chi square for validity did reach significance (chi2 = 6.49, df = 2, p < 0.05) and was strongest for the FACES scale, followed by the Oucher. CONCLUSIONS: The study findings indicated that the FACES and African-American Oucher Scales are valid and reliable tools for measuring pain in children. Among the entire sample and each age group, the FACES scale was the most preferred scale.
Authors: Lindsey L Cohen; Kathleen Lemanek; Ronald L Blount; Lynnda M Dahlquist; Crystal S Lim; Tonya M Palermo; Kristine D McKenna; Karen E Weiss Journal: J Pediatr Psychol Date: 2007-11-17
Authors: Susan M Abdel-Rahman; Shasha Bai; Patricia A Porter-Gill; Grace A Goode; Gregory L Kearns Journal: Paediatr Drugs Date: 2020-11-25 Impact factor: 3.022
Authors: L Coombes; K Bristowe; C Ellis-Smith; J Aworinde; L K Fraser; J Downing; M Bluebond-Langner; L Chambers; F E M Murtagh; R Harding Journal: Qual Life Res Date: 2021-03-18 Impact factor: 4.147
Authors: Jennifer Horst; Melissa Frei-Jones; Elena Deych; William Shannon; Evan D Kharasch Journal: Pediatr Blood Cancer Date: 2016-08-30 Impact factor: 3.167
Authors: Matthew P Myrvik; Amanda M Brandow; Amy L Drendel; Ke Yan; Raymond G Hoffmann; Julie A Panepinto Journal: Pediatr Blood Cancer Date: 2013-06-17 Impact factor: 3.167